iRhythm Holdings (IRTC) Interest Coverage Ratio (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | iRhythm Holdings | 3.55 Bn | 3.00 Bn | 141.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -814.89% |
| Dec 31, 2025 | 126.79% |
| Sep 30, 2025 | 54.99% |
| Jun 30, 2025 | 42.62% |
| Mar 31, 2025 | -708.80% |
| Dec 31, 2024 | 91.86% |
| Sep 30, 2024 | -117.77% |
| Jun 30, 2024 | 47.97% |
| Mar 31, 2024 | 67.97% |
| Dec 31, 2023 | -39.84% |
| Sep 30, 2023 | -31.27% |
| Jun 30, 2023 | 45.45% |
| Mar 31, 2023 | -103.52% |
| Dec 31, 2022 | 40.50% |
| Sep 30, 2022 | 29.42% |
| Jun 30, 2022 | -103.34% |
| Mar 31, 2022 | 81.57% |
| Dec 31, 2021 | -55.59% |
| Sep 30, 2021 | -50.77% |
| Jun 30, 2021 | 32.50% |
| Mar 31, 2021 | -220.09% |
| Dec 31, 2020 | -106.79% |
| Sep 30, 2020 | 76.59% |
| Jun 30, 2020 | -119.22% |
| Mar 31, 2020 | 47.57% |
| Dec 31, 2019 | -3.13% |
| Sep 30, 2019 | -85.93% |
| Jun 30, 2019 | -19.71% |
| Mar 31, 2019 | 18.02% |
| Dec 31, 2018 | -128.48% |
| Sep 30, 2018 | 27.85% |
| Jun 30, 2018 | -20.18% |
| Mar 31, 2018 | 2.47% |
| Dec 31, 2017 | -82.46% |
| Sep 30, 2017 | 1.65% |
| Jun 30, 2017 | -22.26% |
| Mar 31, 2017 | -14.18% |
| Dec 31, 2016 | -53.04% |
| Sep 30, 2016 | 28.24% |
| Jun 30, 2016 | 24.86% |
| Mar 31, 2016 | 48.27% |
| Dec 31, 2015 | 52.19% |